Class 3 Medicines Recall: Kimmtrak 200 Micrograms/ml Concentrate For Solution For Infusion, Immunocore Limited, El(25)a/28
Kimmtrak Recall Summary Immunocore Limited is recalling certain batches of Kimmtrak 200 micrograms/mL (a cancer treatment infusion) in the United Kingdom because testing showed the drug's potency had decreased over time. The company is taking this precautionary step as other safety and quality tests came back normal. This recall affects patients in the UK who may have received affected batches of this medication.
- Recalling firm
- Kimmtrak 200 micrograms/mL concentrate for solution for infusion
- Reason
- Immunocore Limited is recalling the batches listed below as a precautionary measure. The recall is due to a decrease in potency identified during stability testing. All other stability test results remain within specification.
- Classification
- Class II
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2025-06-25
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/e26f309d-bb80-43a2-802b-7fb376edd2d5